Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation

Alfonso L. Sabater, Enrique J. Andreu, María García-Guzmán, Tania López, Gloria Abizanda, Victor L Perez Quinones, Javier Moreno-Montañés, Felipe Prósper

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

PURPOSE. The purpose of this study was to develop a culture method for expansion of corneal endothelial cells (CEC) based on the combined activation of PI3K/Akt and Smad2. METHODS. Morphology, proliferation, and migration of cultured rabbit and nonhuman primate CEC were examined in the presence of the PI3K/Akt activators IGF-1 and heregulin beta in combination with the Smad2 activator activin A. Phenotypic characterization of CEC was performed at the RNA and protein levels. Cell pump function and transepithelial electric resistance were used for in vitro functional assessment of CEC. Finally, ex vivo-expanded rabbit CEC were transplanted into a model of endothelial damage in rabbit corneas. RESULTS. Treatment of rabbit and nonhuman primate CEC in vitro with IGF-1, heregulin beta, and activin A induced an upregulation of PI3K/Akt and Smad2 signaling pathways and an increase in proliferation and migration of CEC expressing ZO-1, connexin-43, and Naþ/Kþ- ATPase. Cell pump function evaluation revealed the complete functionality of cultured CEC. Injection of rabbit CEC successfully produced recovery of normal corneal thickness in a rabbit model of endothelial dysfunction. CONCLUSIONS. We demonstrated that the combined activation of PI3K/Akt and Smad2 results in in vitro expansion of phenotypic and functional CEC. Expanded cells were able to contribute to restoration of corneal endothelium in a rabbit model. These findings may represent a new therapeutic approach for treating corneal endothelial diseases.

Original languageEnglish (US)
Pages (from-to)745-754
Number of pages10
JournalInvestigative Ophthalmology and Visual Science
Volume58
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Phosphatidylinositol 3-Kinases
Endothelial Cells
Cell Proliferation
Rabbits
Neuregulin-1
Insulin-Like Growth Factor I
Primates
Inhibin-beta Subunits
Corneal Diseases
Corneal Endothelium
Connexin 43
Electric Impedance
Cornea
Up-Regulation
RNA
Injections
Therapeutics

Keywords

  • Corneal endothelial cell proliferation
  • Corneal endothelial cell transplantation
  • Corneal endothelial regeneration

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Sabater, A. L., Andreu, E. J., García-Guzmán, M., López, T., Abizanda, G., Perez Quinones, V. L., ... Prósper, F. (2017). Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation. Investigative Ophthalmology and Visual Science, 58(2), 745-754. https://doi.org/10.1167/iovs.16-20817

Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation. / Sabater, Alfonso L.; Andreu, Enrique J.; García-Guzmán, María; López, Tania; Abizanda, Gloria; Perez Quinones, Victor L; Moreno-Montañés, Javier; Prósper, Felipe.

In: Investigative Ophthalmology and Visual Science, Vol. 58, No. 2, 01.02.2017, p. 745-754.

Research output: Contribution to journalArticle

Sabater, AL, Andreu, EJ, García-Guzmán, M, López, T, Abizanda, G, Perez Quinones, VL, Moreno-Montañés, J & Prósper, F 2017, 'Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation', Investigative Ophthalmology and Visual Science, vol. 58, no. 2, pp. 745-754. https://doi.org/10.1167/iovs.16-20817
Sabater AL, Andreu EJ, García-Guzmán M, López T, Abizanda G, Perez Quinones VL et al. Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation. Investigative Ophthalmology and Visual Science. 2017 Feb 1;58(2):745-754. https://doi.org/10.1167/iovs.16-20817
Sabater, Alfonso L. ; Andreu, Enrique J. ; García-Guzmán, María ; López, Tania ; Abizanda, Gloria ; Perez Quinones, Victor L ; Moreno-Montañés, Javier ; Prósper, Felipe. / Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation. In: Investigative Ophthalmology and Visual Science. 2017 ; Vol. 58, No. 2. pp. 745-754.
@article{ecbb319ec1234960b8711f1b6ee32bef,
title = "Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation",
abstract = "PURPOSE. The purpose of this study was to develop a culture method for expansion of corneal endothelial cells (CEC) based on the combined activation of PI3K/Akt and Smad2. METHODS. Morphology, proliferation, and migration of cultured rabbit and nonhuman primate CEC were examined in the presence of the PI3K/Akt activators IGF-1 and heregulin beta in combination with the Smad2 activator activin A. Phenotypic characterization of CEC was performed at the RNA and protein levels. Cell pump function and transepithelial electric resistance were used for in vitro functional assessment of CEC. Finally, ex vivo-expanded rabbit CEC were transplanted into a model of endothelial damage in rabbit corneas. RESULTS. Treatment of rabbit and nonhuman primate CEC in vitro with IGF-1, heregulin beta, and activin A induced an upregulation of PI3K/Akt and Smad2 signaling pathways and an increase in proliferation and migration of CEC expressing ZO-1, connexin-43, and Na{\th}/K{\th}- ATPase. Cell pump function evaluation revealed the complete functionality of cultured CEC. Injection of rabbit CEC successfully produced recovery of normal corneal thickness in a rabbit model of endothelial dysfunction. CONCLUSIONS. We demonstrated that the combined activation of PI3K/Akt and Smad2 results in in vitro expansion of phenotypic and functional CEC. Expanded cells were able to contribute to restoration of corneal endothelium in a rabbit model. These findings may represent a new therapeutic approach for treating corneal endothelial diseases.",
keywords = "Corneal endothelial cell proliferation, Corneal endothelial cell transplantation, Corneal endothelial regeneration",
author = "Sabater, {Alfonso L.} and Andreu, {Enrique J.} and Mar{\'i}a Garc{\'i}a-Guzm{\'a}n and Tania L{\'o}pez and Gloria Abizanda and {Perez Quinones}, {Victor L} and Javier Moreno-Monta{\~n}{\'e}s and Felipe Pr{\'o}sper",
year = "2017",
month = "2",
day = "1",
doi = "10.1167/iovs.16-20817",
language = "English (US)",
volume = "58",
pages = "745--754",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "2",

}

TY - JOUR

T1 - Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation

AU - Sabater, Alfonso L.

AU - Andreu, Enrique J.

AU - García-Guzmán, María

AU - López, Tania

AU - Abizanda, Gloria

AU - Perez Quinones, Victor L

AU - Moreno-Montañés, Javier

AU - Prósper, Felipe

PY - 2017/2/1

Y1 - 2017/2/1

N2 - PURPOSE. The purpose of this study was to develop a culture method for expansion of corneal endothelial cells (CEC) based on the combined activation of PI3K/Akt and Smad2. METHODS. Morphology, proliferation, and migration of cultured rabbit and nonhuman primate CEC were examined in the presence of the PI3K/Akt activators IGF-1 and heregulin beta in combination with the Smad2 activator activin A. Phenotypic characterization of CEC was performed at the RNA and protein levels. Cell pump function and transepithelial electric resistance were used for in vitro functional assessment of CEC. Finally, ex vivo-expanded rabbit CEC were transplanted into a model of endothelial damage in rabbit corneas. RESULTS. Treatment of rabbit and nonhuman primate CEC in vitro with IGF-1, heregulin beta, and activin A induced an upregulation of PI3K/Akt and Smad2 signaling pathways and an increase in proliferation and migration of CEC expressing ZO-1, connexin-43, and Naþ/Kþ- ATPase. Cell pump function evaluation revealed the complete functionality of cultured CEC. Injection of rabbit CEC successfully produced recovery of normal corneal thickness in a rabbit model of endothelial dysfunction. CONCLUSIONS. We demonstrated that the combined activation of PI3K/Akt and Smad2 results in in vitro expansion of phenotypic and functional CEC. Expanded cells were able to contribute to restoration of corneal endothelium in a rabbit model. These findings may represent a new therapeutic approach for treating corneal endothelial diseases.

AB - PURPOSE. The purpose of this study was to develop a culture method for expansion of corneal endothelial cells (CEC) based on the combined activation of PI3K/Akt and Smad2. METHODS. Morphology, proliferation, and migration of cultured rabbit and nonhuman primate CEC were examined in the presence of the PI3K/Akt activators IGF-1 and heregulin beta in combination with the Smad2 activator activin A. Phenotypic characterization of CEC was performed at the RNA and protein levels. Cell pump function and transepithelial electric resistance were used for in vitro functional assessment of CEC. Finally, ex vivo-expanded rabbit CEC were transplanted into a model of endothelial damage in rabbit corneas. RESULTS. Treatment of rabbit and nonhuman primate CEC in vitro with IGF-1, heregulin beta, and activin A induced an upregulation of PI3K/Akt and Smad2 signaling pathways and an increase in proliferation and migration of CEC expressing ZO-1, connexin-43, and Naþ/Kþ- ATPase. Cell pump function evaluation revealed the complete functionality of cultured CEC. Injection of rabbit CEC successfully produced recovery of normal corneal thickness in a rabbit model of endothelial dysfunction. CONCLUSIONS. We demonstrated that the combined activation of PI3K/Akt and Smad2 results in in vitro expansion of phenotypic and functional CEC. Expanded cells were able to contribute to restoration of corneal endothelium in a rabbit model. These findings may represent a new therapeutic approach for treating corneal endothelial diseases.

KW - Corneal endothelial cell proliferation

KW - Corneal endothelial cell transplantation

KW - Corneal endothelial regeneration

UR - http://www.scopus.com/inward/record.url?scp=85011541451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011541451&partnerID=8YFLogxK

U2 - 10.1167/iovs.16-20817

DO - 10.1167/iovs.16-20817

M3 - Article

C2 - 28146239

AN - SCOPUS:85011541451

VL - 58

SP - 745

EP - 754

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 2

ER -